DE60233601D1 - Verwendung von bestimmten Cyclolignanen - Google Patents
Verwendung von bestimmten CyclolignanenInfo
- Publication number
- DE60233601D1 DE60233601D1 DE60233601T DE60233601T DE60233601D1 DE 60233601 D1 DE60233601 D1 DE 60233601D1 DE 60233601 T DE60233601 T DE 60233601T DE 60233601 T DE60233601 T DE 60233601T DE 60233601 D1 DE60233601 D1 DE 60233601D1
- Authority
- DE
- Germany
- Prior art keywords
- cyclolignans
- certain
- certain cyclolignans
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
- C07D317/54—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/70—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with ring systems containing two or more relevant rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Oncology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0102168A SE0102168D0 (sv) | 2001-06-19 | 2001-06-19 | New use and new compounds |
US30043101P | 2001-06-26 | 2001-06-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60233601D1 true DE60233601D1 (de) | 2009-10-15 |
Family
ID=26655492
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60233601T Expired - Lifetime DE60233601D1 (de) | 2001-06-19 | 2002-06-19 | Verwendung von bestimmten Cyclolignanen |
Country Status (5)
Country | Link |
---|---|
JP (1) | JP2009242406A (no) |
KR (1) | KR20040030686A (no) |
AU (2) | AU2009201542B2 (no) |
DE (1) | DE60233601D1 (no) |
NO (1) | NO20035647L (no) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100971364B1 (ko) * | 2009-12-28 | 2010-07-20 | 명 하 윤 | 굴삭기 그라브 실린더의 유압 분배용 어댑터 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU585936B2 (en) * | 1984-12-28 | 1989-06-29 | Conpharm A.B. | Pharmaceutically active podophyllotoxins |
JPH09194368A (ja) * | 1996-01-11 | 1997-07-29 | Pola Chem Ind Inc | ポドフィロトキシン誘導体及びそれからなる新規細胞分化誘導剤 |
-
2002
- 2002-06-19 DE DE60233601T patent/DE60233601D1/de not_active Expired - Lifetime
- 2002-06-19 KR KR10-2003-7016623A patent/KR20040030686A/ko not_active Application Discontinuation
-
2003
- 2003-12-17 NO NO20035647A patent/NO20035647L/no unknown
-
2009
- 2009-04-20 AU AU2009201542A patent/AU2009201542B2/en not_active Expired - Fee Related
- 2009-06-03 JP JP2009134006A patent/JP2009242406A/ja active Pending
-
2010
- 2010-02-10 AU AU2010200488A patent/AU2010200488A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2009242406A (ja) | 2009-10-22 |
KR20040030686A (ko) | 2004-04-09 |
NO20035647L (no) | 2004-02-18 |
AU2009201542A1 (en) | 2009-05-14 |
AU2010200488A1 (en) | 2010-03-04 |
AU2009201542B2 (en) | 2011-06-23 |
NO20035647D0 (no) | 2003-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE50212455D1 (de) | Verwendung von Dimerdiolen | |
DE60221977D1 (de) | Pro-pharmakon von cox-2-inhibitoren | |
DE60236226D1 (de) | Verbesserung der Altersweitsichtigkeit | |
DE60217432D1 (de) | Verwendungen von Kohlenstofffasern | |
DK1360169T3 (da) | Succinatsalt af O-desmethyl-venlafaxin | |
DE60211601D1 (de) | Bereitstellung von positionsabhängigen Inhalten | |
ATE510556T1 (de) | Verwendung von erythropoietin | |
DE02784674T1 (de) | Quantifizierung von polypeptiden | |
DE60204093D1 (de) | Substanzgemisch von Triphenylamindimeren | |
DE502004011575D1 (de) | Verwendung von Dioldimerfettsäureestern | |
ITMI20021038A0 (it) | Disposizione di elettrodi | |
NO20041968L (no) | Anvendelse av cystationin | |
ATE275390T1 (de) | Verwendung von kationischen zubereitungen | |
DE60227828D1 (de) | E von schmelzkleber | |
DE60318819D1 (de) | Hitzestabile mutanten von stärkebiosyntheseenzymen | |
DE50311406D1 (de) | Verwendung von Formkörpern | |
ATE556564T1 (de) | Zuweisung von zeitschlitzen | |
ATE395917T1 (de) | Kombination von docetaxel mit flavopiridol | |
DE60007360T2 (de) | Amorphe modifikation von torasemid | |
ATE272388T1 (de) | Verwendung von kationischen zubereitungen | |
DE60330315D1 (de) | Acylfluorid-aktivierung von mit carboxysilyl beschichteten glassubstraten | |
DE60233601D1 (de) | Verwendung von bestimmten Cyclolignanen | |
DE50205590D1 (de) | Ummantelung von leiterbahnen | |
DE50203046D1 (de) | Verwendung von Esterquats | |
ATE348606T1 (de) | Neue verwendung von pipatalin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |